Cargando…
Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
SIMPLE SUMMARY: Unabated tumor growth, metastasis, and resistance to hormone therapy and/or to chemotherapy constitute serious impediments for combating breast cancer (BC). With the exception of targeted anti-HER2/neu therapy and combination therapies, there have been no radical changes in the stand...
Autores principales: | Borcherding, Dana C., Hugo, Eric R., Fox, Sejal R., Jacobson, Eric M., Hunt, Brian G., Merino, Edward J., Ben-Jonathan, Nira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198871/ https://www.ncbi.nlm.nih.gov/pubmed/34071395 http://dx.doi.org/10.3390/cancers13112662 |
Ejemplares similares
-
Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1
por: Ben-Jonathan, Nira, et al.
Publicado: (2019) -
Dopamine Receptors in Human Adipocytes: Expression and Functions
por: Borcherding, Dana C., et al.
Publicado: (2011) -
Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor-α–Positive and –Negative Breast Cancer Cells
por: LaPensee, Elizabeth W., et al.
Publicado: (2009) -
Placental Lactogen Is Expressed but Is Not Translated into Protein in Breast Cancer
por: Tuttle, Traci R., et al.
Publicado: (2014) -
Prolactin and Prolactin Receptor Expression in Rat,
Small Intestine, Intraepithelial Lymphocytes During
Neonatal Developmen
por: Urtishak, Sandra L., et al.
Publicado: (2001)